9 key vaccine advances in SA: eligible groups, G7 pledge & more

Following President Cyril Ramaphosa's address on new lockdown rules on Sunday, we've put together 8 key Covid-19 vaccination advances, including eligible age groups, G7 multimillion vaccine pledge and planned rollout dates.

0


During his speech on new lockdown rules on Sunday, President Cyril Ramaphosa welcomed Joe Biden’s 17 million vaccine pledge to South Africa. Below is a summary of all the key developments around Covid-19 vaccines; anything from eligible age groups, to targeted rollout dates and the US (G7) vaccine funding.

  • From Thursday,  July 15, those over 35 years of age will be able to register on the Electronic Vaccination Data System. Ramaphosa said plans are afoot to commence with vaccinations for the 35+ group from August 1. 
  • Ramaphosa said plans are afoot to commence with vaccinations for the 35+ group from August 1. 
  • Government and the private sector are working together to build additional capacity to vaccinate many more people a day. Currently both the 60+ and 50+ age groups are being vaccinated.
  • Ramaphosa added that the pace of vaccination has more than doubled in the last month, and will continue to increase. Presently, nearly 190,000 people are on average being vaccinated each weekday.
  • To date, over 4.2 million people in South Africa have received a vaccine dose since the height of the second wave, with one million of these having been done over the past seven weekdays.
  • He said the government is negotiating to have the vaccine drug substance produced here in South Africa, “so that we have a fully-owned African vaccine manufactured on African soil in a number of countries on our continent”.
  • The African Union, through the South African office as the AU COVID-19 champion, and the EU have reached a historic agreement that will see Aspen delivering over 17 million Johnson & Johnson vaccine doses to South Africa and other African countries over the next three months, commencing in late July.
  • He also welcomed SAHPRA’s approved of CoronaVac vaccine from China for use in South Africa in the near future. Manufactured by Sinovac Life Sciences Co, and imported by Curanto Pharma, the vaccine is administered as two doses of 0,5ml, given intramuscularly, with the second dose administered between 14 and 28 days after the first dose.
Previous articleLockdown update: South Africa stays on Level 4 for 14 more days
Next articleIdols SA S17 off to a good start: here’s who impressed the judges
A Tshwane University of Technology journalism graduate, Tankiso Komane has a vast experience in print & broadcast media business and has worked for some of the country’s biggest daily newspapers, including The Sowetan, The Citizen, The Times, and The New Age. Through her varied work as a journalist, notably as a copywriter for SABC1 (On-Air promotions) and as a publicist for Onyx Communications, she has developed an in-depth understanding of the nature of the media business and how to use it for the purpose of exposure. Her expertise in journalism across various disciplines, coupled with a good reputation, has laid the foundation of a new kind "trust in Journalism" as the media ecosystem continues to digitally evolve.